SEC Form 4 · accession 0001209191-19-008135
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aron Marc Knickerbocker
Officer — President & CEO · Director
Period of report
Feb 5, 2019
Accepted (ET)
Feb 7, 2019 · 5:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 5, 2019 | F | 2,996 | $11.43 | D | 195,063 | D | |
| Common Stock | holding | — | — | — | 14,238 | I | By the Aron M. Knickerbocker Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 641 shares acquired on May 15, 2018 and 452 shares acquired on November 15, 2018 pursuant to Five Prime Therapeutics, Inc.'s 2013 Employee Stock Purchase Plan.